M. Craig Hall

4.7k total citations · 2 hit papers
57 papers, 3.4k citations indexed

About

M. Craig Hall is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, M. Craig Hall has authored 57 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 21 papers in Surgery. Recurrent topics in M. Craig Hall's work include Bladder and Urothelial Cancer Treatments (15 papers), Prostate Cancer Treatment and Research (14 papers) and Renal cell carcinoma treatment (12 papers). M. Craig Hall is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Prostate Cancer Treatment and Research (14 papers) and Renal cell carcinoma treatment (12 papers). M. Craig Hall collaborates with scholars based in United States, United Kingdom and Australia. M. Craig Hall's co-authors include Arthur I. Sagalowsky, Peter E. Clark, Claus G. Roehrborn, Thomas Carmody, Brian R. Matlaga, Ronald J. Zagoria, Guido Dalbagni, Sam S. Chang, John D. Seigne and Raj S. Pruthi and has published in prestigious journals such as Cancer, Cancer Research and Clinical Cancer Research.

In The Last Decade

M. Craig Hall

56 papers receiving 3.4k citations

Hit Papers

Guideline for the Management of Nonmuscle Invasive Bladde... 1998 2026 2007 2016 2007 1998 200 400 600

Peers

M. Craig Hall
Dragan Golijanin United States
F. Guillé France
Kirk J. Wojno United States
Hans Stricker United States
Anirban P. Mitra United States
O Alfthan Finland
Dragan Golijanin United States
M. Craig Hall
Citations per year, relative to M. Craig Hall M. Craig Hall (= 1×) peers Dragan Golijanin

Countries citing papers authored by M. Craig Hall

Since Specialization
Citations

This map shows the geographic impact of M. Craig Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Craig Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Craig Hall more than expected).

Fields of papers citing papers by M. Craig Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Craig Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Craig Hall. The network helps show where M. Craig Hall may publish in the future.

Co-authorship network of co-authors of M. Craig Hall

This figure shows the co-authorship network connecting the top 25 collaborators of M. Craig Hall. A scholar is included among the top collaborators of M. Craig Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Craig Hall. M. Craig Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zabaleta, Jovanny, Hui‐Yi Lin, M. Craig Hall, et al.. (2009). Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis. 30(8). 1358–1362. 50 indexed citations
2.
Clark, Peter E., et al.. (2006). Complementary and Alternative Medicine for Advanced Prostate Cancer. Urologic Clinics of North America. 33(2). 237–246. 28 indexed citations
3.
Clark, Peter E., M. Craig Hall, Lester S. Borden, et al.. (2006). Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology. 67(6). 1257–1261. 66 indexed citations
4.
Hall, M. Craig, Peter E. Clark, Shu‐Chun Chuang, et al.. (2005). DNA damage levels in prostate cancer cases and controls. Carcinogenesis. 27(6). 1187–1193. 40 indexed citations
5.
Clark, Peter E., et al.. (2005). Recent advances in the treatment of bladder cancer. Expert Review of Anticancer Therapy. 5(6). 1023–1030. 2 indexed citations
6.
Clark, Peter E. & M. Craig Hall. (2005). Contemporary Management of the Urethra in Patients After Radical Cystectomy for Bladder Cancer. Urologic Clinics of North America. 32(2). 199–206. 10 indexed citations
7.
Borden, Lester S., Peter E. Clark, & M. Craig Hall. (2004). Bladder cancer. Current Opinion in Oncology. 16(3). 257–262. 13 indexed citations
8.
Clark, Peter E., M. Craig Hall, Antonius A. Miller, et al.. (2004). Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma. Urology. 63(6). 1061–1065. 15 indexed citations
9.
Chang, Sam S., Mitchell C. Benson, Steven C. Campbell, et al.. (2004). Society of Urologic Oncology position statement: Redefining the management of hormone‐refractory prostate carcinoma. Cancer. 103(1). 11–21. 24 indexed citations
10.
Matlaga, Brian R., James Lovato, & M. Craig Hall. (2003). Randomized prospective trial of a novel local anesthetic technique for extensive prostate biopsy. Urology. 61(5). 972–976. 36 indexed citations
11.
Borden, Lester S., Peter E. Clark, & M. Craig Hall. (2003). Bladder cancer. Current Opinion in Oncology. 15(3). 227–233. 40 indexed citations
12.
Patton, Suzanne E., M. Craig Hall, & Haluk Özen. (2002). Bladder cancer. Current Opinion in Oncology. 14(3). 265–272. 27 indexed citations
13.
Lee, W. Robert, M. Craig Hall, Richard P. McQuellon, L. Douglas Case, & David L. McCullough. (2001). A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 51(3). 614–623. 103 indexed citations
14.
Assimos, Dean G., M. Craig Hall, & Jacob A. Martin. (2000). URETEROSCOPIC MANAGEMENT OF PATIENTS WITH UPPER TRACT TRANSITIONAL CELL CARCINOMA. Urologic Clinics of North America. 27(4). 751–760. 21 indexed citations
15.
Huizinga, T., V. Keijsers, G. Yanni, et al.. (2000). Are differences in interleukin 10 production associated with joint damage?. Lara D. Veeken. 39(11). 1180–1188. 79 indexed citations
16.
Lee, W. Robert, et al.. (1999). Recent advances in the treatment of prostate cancer. Annals of Oncology. 10(8). 891–898. 24 indexed citations
18.
Hall, M. Craig, Nora M. Navone, Patricia Troncoso, et al.. (1995). Frequency and characterization of p53 mutations in clinically localized prostate cancer. Urology. 45(3). 470–475. 53 indexed citations
19.
Zhau, Haiyen E., Leland W.K. Chung, Patricia Troncoso, et al.. (1995). Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations. Urologic Oncology Seminars and Original Investigations. 1(2). 51–63. 17 indexed citations
20.
Hall, M. Craig, Patricia Troncoso, Alan Pollack, et al.. (1994). Significance of tumor angiogenesis inclinically localized prostate carcinoma treated with external beam radiotherapy. Urology. 44(6). 869–875. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026